Company to conduct a Phase 1 Drug-Drug Interaction StudyPhase 2 filing on track for Q1 2025SOUTH SAN FRANCISCO, Calif., Oct. 22, 2024 (GLOBE ...

SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...

In this medical fiction tale, a journalist's attempt to expose what he believes to be a secret gender-affirming care clinic in a hospital basement turns deadly.

The new drug application resubmission of rivoceranib/camrelizumab in the first line in unresectable or metastatic ...

A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.

TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) is one of 225 public companies in the “Surgical & medical instruments” ...

October is Liver Cancer Awareness Month. Liver cancer is the third-leading cause of cancer-related deaths worldwide, and the ...

Researchers found that patients diagnosed with HCC during 2013-2019 were less likely to die from HCC or from any cause than patients who were diagnosed during 2006-2012.

From “Boy Meets World” actress Danielle Fishel discussing her breast cancer surgery to a young TikTok star dying from a rare ...

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...